Use of Electroconvulsive Therapy in Central-Eastern European Countries: An Overview

Gazdag, Gábor; Dragašek, Jozef; Takács, Rozália; Lõokene, Margus; Sobów, Tomasz; Olekseev, Aleksey; Ungvári, Gábor S.

doi:10.24869/psyd.2017.136

Cited by 28 publications

(45 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, heterogeneity in ECT delivery, both nationally and internationally, is a concern. A comprehensive contemporary review of worldwide ECT practice and variability demonstrated substantial heterogeneity [2] with high variability in the United States [3][4][5], Canada [6,7], Australia [8], the Netherlands [9], Belgium [10], Central and Eastern Europe [11], Greece [12], Spain [13], the Baltic States [14], Saudi Arabia [15], South Africa [16], Nigeria [17], Russia [18], Thailand [19], Japan, [20], India [21] and other Asian countries [22,23].…”

Section: Introductionmentioning

confidence: 99%

“…sine wave devices), and inconsistently uses electroencephalogram (EEG) monitoring, anesthesia and paralytic medications. This is most likely due to limited financial or medical resources and contrasts with more contemporary ECT practice in North America, Western Europe, Australia, and New Zealand where brief or ultrabrief pulse stimulation, active EEG monitoring and routine anesthesia are more regularly used [2,11,22].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Stone

Collier

2020

Personalized Medicine in Psychiatry

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Stone

Collier

2020

Personalized Medicine in Psychiatry

View full text Add to dashboard Cite

“…A general overview of use of electroconvulsive therapy in Central-Eastern European countries was recently given by Gazdag et al (2017). ECT practice in this region shows a heterogeneous picture as of utilization rate, prevailing indications and technical parameters.…”

Section: Discussionmentioning

confidence: 99%

Maintenance Electroconvulsive Therapy in Schizophrenia

Krepela

Hosák²,

Pachlova³

et al. 2019

Psychiat Danub

View full text Add to dashboard Cite

Background: The aim of our retrospective naturalistic observational study was to describe the use of maintenance electroconvulsive therapy (M-ECT) in chronic pharmacoresistant schizophrenia. Subjects and methods: We delineated 19 cases of chronic pharmacoresistant schizophrenia (females N=12) recently treated with maintenance electroconvulsive therapy at the Havlickuv Brod Psychiatric Hospital in the Czech Republic. Demographic, clinical and treatment variables were recorded. Results: M-ECT, when applied weekly to monthly mostly over a period of several years, was of no benefit in the treatment of chronic hallucinations and/or delusions. However, it did prove beneficial (p<0.001) in removing chronic serious symptoms like suicidal or violent behavior, automutilation, refusal of food or liquids, stupor or catatonia. Even though almost all of our patients remained hospitalized, we were nonetheless able to transfer them to an unlocked psychiatric ward and let them out for walks or occupational therapy with almost no need for using restraint. No serious adverse side effects of M-ECT were found. Conclusions: Our study is limited by using only one simple standardized measurement (Clinical Global Impression-Severity) that was retrospective. Another limitation of our retrospective study was that the subjects had not been regularly tested for their cognitive functions. According to our results, M-ECT mitigates the impact of the disease and improves social functioning of the patients. M-ECT does not treat chronic schizophrenia but does make the lives of patients more tolerable. We suggest further research into M-ECT and its clinical application in chronic pharmacoresistant schizophrenia.

show abstract

“…[178][179][180] Globally, use of ECT is heterogeneous, [181][182][183][184][185][186][187] and geographic limitations, lack of training, lack of anesthesiologists, cost, stigma, health-care inequity, and national laws have been described as obstacles to access. 183,[188][189][190][191][192] Outdated treatment protocols and heavy use for conditions less responsive to ECT (ie, schizophrenia) are common across Asia, based on a study of 334 institutions in 29 Asian countries. 193 In Scandinavia, ECT is widely available and tends to follow updated treatment guidelines, but unequal geographic distribution can limit access.…”

Section: Under-recognition Of Catatoniamentioning

confidence: 99%

<p>Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives</p>

Lloyd¹,

Silverman²,

Kugler³

et al. 2020

NDT

View full text Add to dashboard Cite

Catatonia is a serious, common syndrome of motoric and behavioral dysfunction, which carries high morbidity and mortality. Electroconvulsive therapy (ECT) is the definitive treatment for catatonia, but access to ECT for the treatment of catatonia remains inappropriately limited. Catatonia is observable, detectable, and relevant to various medical specialties, but underdiagnosis impedes the delivery of appropriate treatment and heightens risk of serious complications including iatrogenesis. Current understanding of catatonia's pathophysiology links it to the current understanding of ECT's mechanism of action. Definitive catatonia care requires recognition of the syndrome, workup to identify and treat the underlying cause, and effective management including appropriate referral for ECT. Even when all of these conditions are met, and despite well-established data on the safety and efficacy of ECT, stigma surrounding ECT and legal restrictions for its use in catatonia are additional critical barriers. Addressing the underdiagnosis of catatonia and barriers to its treatment with ECT is vital to improving outcomes for patients. While no standardized protocols for treatment of catatonia with ECT exist, a large body of research guides evidence-based care and reveals where additional research is warranted. The authors conducted a review of the literature on ECT as a treatment for catatonia. Based on the review, the authors offer strategies and future directions for improving access to ECT for patients with catatonia, and propose an algorithm for the treatment of catatonia with ECT.

show abstract

Use of Electroconvulsive Therapy in Central-Eastern European Countries: An Overview

Abstract: SUMMARY Though a number of reports on the use of electroconvulsive therapy (ECT) has been published from the Central-Eastern

Cited by 28 publications

References 13 publications

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Maintenance Electroconvulsive Therapy in Schizophrenia

<p>Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives</p>

Contact Info

Product

Resources

About